ProCE Banner Series

Shaping the Future of ALL: Advancing Novel Immune-Targeted Therapies to Address Unmet Clinical Needs

Expert hematology/oncology faculty discuss the latest developments and clinical rationale with novel immune-targeted therapies for patients with ALL. This program will also discuss which patients may be eligible for ongoing ALL trials with these therapies.

  AMA
Who Should Attend

This educational activity is intended for hematologists, oncologists, and other healthcare professionals who care for patients with ALL. 

All Events

Shaping the Future of ALL: Advancing Novel Immune-Targeted Therapies to Address Unmet Clinical Needs

Upcoming Events

June

25

2025

6:00 PM - 7:30 PM Eastern Time (ET)

Virtual

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
This activity aims to improve learners' knowledge, confidence, and competence in integrating novel immune-targeted therapies into the care of patients with ALL.

Target Audience
This educational activity is intended for hematologists, oncologists, and other healthcare professionals who care for patients with ALL. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Educate colleagues and patients on the clinical rationale for novel T-cell engager therapies in ALL

  • Evaluate how the mechanism of action of investigational therapeutics impacts safety, efficacy, and persistence in ALL

  • Appraise new safety and efficacy data on novel immune-targeted therapies for patients with ALL

  • Identify patients with ALL who may be eligible for ongoing clinical trials of novel immune-targeted therapies

Accreditation

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/67167f3d10da3.png

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For ABIM MOC points, your information will be shared with the ABIM through CCO's Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

By sharing your Diplomate Board ID # and DOB, you are giving Clinical Care Options, LLC permission to use this information/data to report your participation to these Boards via the Joint Accreditation Program and Activity Reporting System (JA-PARS).

CME Passport

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/662be69741e7b.png

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC

Supported by an educational grant from AstraZeneca.